Prevalence of Overactive Bladder Syndrome (OABS) Among Women with Gynaecological Problems and Its Risk Factors in a Tertiary Hospital, Negeri Sembilan, Malaysia: Implication for Primary Healthcare Providers

Overview

Journal Malays Fam Physician

Specialty Public Health

Date 2016 Apr 22

PMID 27099656

Citations 2

Authors

S M Ahmad

S S Aznal

S W Tham

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this paper was to determine the prevalence of overactive bladder syndrome (OABS) and its risk factors among patients with other gynaecological problems.

Methods: This study was conducted on women aged more than 18 years who attended the gynaecology clinic for various diagnoses other than urinary problems at a tertiary hospital in Negeri Sembilan, Malaysia, for a period of 6 months. Data on patient's profile, symptoms and risk factors for overactive bladder (OAB) were prospectively collected using a structured questionnaire adapted from ICIQ (international consultation on incontinence questionnaire). Exclusion criteria included patients with confirmed diagnosis of stress incontinence or OAB, neurological impairment, gynaecological malignancy and those with a previous history of pelvic radiation. Chi-square test and logistic regression test were used in the statistical analysis. We presented the odds ratio (OR) and 95% confidence interval for each of the OAB symptoms with p-value of 0.05.

Results: The prevalence of OAB among the patients (n = 573) in this study was 19.1%. History of giving births to macrosomic babies and presence of utero-vaginal prolapse (UVP) were shown to be significantly associated with OAB in the multivariate analysis. Other factors were advanced age, high parity and menopausal for more than 5 years. More than half of the patients with the symptoms of OAB did not seek treatment, as they did not think it is necessary.

Conclusion: It is found that the prevalence of OAB is similar with many other studies conducted elsewhere. It was found to be multifactorial, but was highly significantly related with the presence of UVP, especially cystocoele and history of giving births to macrosomic babies.

Citing Articles

Validating 7-items Overactive Bladder Symptom Score (OABSS) through Arabic linguistic version.

Sawaqed F, Suoub M Sci Rep. 2021; 11(1):661.

PMID: 33436744 PMC: 7804958. DOI: 10.1038/s41598-020-79974-9.

Screening: A double-edged sword.

Malays Fam Physician. 2016; 10(2):1.

PMID: 27099655 PMC: 4826575.

References

Wan X, Wang C, Xu D, Guan X, Sun T, Wang K . Disease stigma and its mediating effect on the relationship between symptom severity and quality of life among community-dwelling women with stress urinary incontinence: a study from a Chinese city. J Clin Nurs. 2014; 23(15-16):2170-9. DOI: 10.1111/jocn.12482. View

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U . The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003; 61(1):37-49. DOI: 10.1016/s0090-4295(02)02243-4. View

Stoddart H, Donovan J, Whitley E, Sharp D, Harvey I . Urinary incontinence in older people in the community: a neglected problem?. Br J Gen Pract. 2001; 51(468):548-52. PMC: 1314046. View

Wein A, Rackley R . Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol. 2006; 175(3 Pt 2):S5-10. DOI: 10.1016/S0022-5347(05)00313-7. View

Al-Shaiji T, Radomski S . Relationship between Body Mass Index and Overactive Bladder in Women and Correlations with Urodynamic Evaluation. Int Neurourol J. 2012; 16(3):126-31. PMC: 3469831. DOI: 10.5213/inj.2012.16.3.126. View

Cheung W, Khan N, Choi K, Bluth M, Vincent M . Prevalence, evaluation and management of overactive bladder in primary care. BMC Fam Pract. 2009; 10:8. PMC: 2642771. DOI: 10.1186/1471-2296-10-8. View

Andersson K . The overactive bladder: pharmacologic basis of drug treatment. Urology. 1998; 50(6A Suppl):74-84; discussion 85-9. DOI: 10.1016/s0090-4295(97)00595-5. View

Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog A, Corey R . Prevalence and burden of overactive bladder in the United States. World J Urol. 2003; 20(6):327-36. DOI: 10.1007/s00345-002-0301-4. View

de Boer T, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P . Pelvic organ prolapse and overactive bladder. Neurourol Urodyn. 2009; 29(1):30-9. DOI: 10.1002/nau.20858. View

10.

Jo J, Lee S, Kim Y, Choi H, Kim S, Choi B . Analysis of the risk factors for overactive bladder on the basis of a survey in the community. Korean J Urol. 2012; 53(8):541-6. PMC: 3427838. DOI: 10.4111/kju.2012.53.8.541. View

11.

Duthie J, Wilson D, Herbison G, Wilson D . Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2007; (3):CD005493. DOI: 10.1002/14651858.CD005493.pub2. View

12.

Lapitan M, Chye P . The epidemiology of overactive bladder among females in Asia: a questionnaire survey. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(4):226-31. DOI: 10.1007/s001920170043. View

13.

Coyne K, Matza L, Thompson C . The responsiveness of the Overactive Bladder Questionnaire (OAB-q). Qual Life Res. 2005; 14(3):849-55. DOI: 10.1007/s11136-004-0706-1. View

14.

Currie C, McEwan P, Poole C, O Odeyemi I, Datta S, Morgan C . The impact of the overactive bladder on health-related utility and quality of life. BJU Int. 2006; 97(6):1267-72. DOI: 10.1111/j.1464-410X.2006.06141.x. View

15.

El-Azab A, Shaaban O . Measuring the barriers against seeking consultation for urinary incontinence among Middle Eastern women. BMC Womens Health. 2010; 10:3. PMC: 2835642. DOI: 10.1186/1472-6874-10-3. View

16.

Gormley E, Lightner D, Burgio K, Chai T, Clemens J, Culkin D . Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012; 188(6 Suppl):2455-63. DOI: 10.1016/j.juro.2012.09.079. View

17.

McGrother C, Donaldson M, Thompson J, Wagg A, Tincello D, Manktelow B . Etiology of overactive bladder: a diet and lifestyle model for diabetes and obesity in older women. Neurourol Urodyn. 2012; 31(4):487-95. DOI: 10.1002/nau.21200. View

18.

Low B, Liong M, Yuen K, Chong W, Chee C, Leong W . Study of prevalence, treatment-seeking behavior, and risk factors of women with lower urinary tract symptoms in Northern Malaysia. Urology. 2006; 68(4):751-8. DOI: 10.1016/j.urology.2006.05.021. View

19.

Teleman P, Lidfeldt J, Nerbrand C, Samsioe G, Mattiasson A . Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. BJOG. 2004; 111(6):600-4. DOI: 10.1111/j.1471-0528.2004.00137.x. View

20.

DuBeau C . Interpreting the effect of common medical conditions on voiding dysfunction in the elderly. Urol Clin North Am. 1996; 23(1):11-8. DOI: 10.1016/s0094-0143(05)70289-5. View